Jeffrey S. Heier - Net Worth and Insider Trading
Jeffrey S. Heier Net Worth
The estimated net worth of Jeffrey S. Heier is at least $413,400 dollars as of 2024-11-13. Jeffrey S. Heier is the Director of Ocular Therapeutix Inc and owns about 39,000 shares of Ocular Therapeutix Inc (OCUL) stock worth over $413,400. Details can be seen in Jeffrey S. Heier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey S. Heier has not made any transactions after 2022-05-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey S. Heier
Jeffrey S. Heier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey S. Heier owns 1 companies in total, including Ocular Therapeutix Inc (OCUL) .
Click here to see the complete history of Jeffrey S. Heier’s form 4 insider trades.
Insider Ownership Summary of Jeffrey S. Heier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2022-05-12 | director |
Jeffrey S. Heier Latest Holdings Summary
Jeffrey S. Heier currently owns a total of 1 stock. Jeffrey S. Heier owns 39,000 shares of Ocular Therapeutix Inc (OCUL) as of May 12, 2022, with a value of $413,400.
Latest Holdings of Jeffrey S. Heier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2022-05-12 | 39,000 | 10.60 | 413,400 |
Holding Weightings of Jeffrey S. Heier
Jeffrey S. Heier Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey S. Heier has made a total of 1 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ocular Therapeutix Inc is the acquisition of 15,000 shares on May 12, 2022, which cost Jeffrey S. Heier around $45,750.
Insider Trading History of Jeffrey S. Heier
- 1
Jeffrey S. Heier Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey S. Heier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey S. Heier is 44.98%. GuruFocus also compares Jeffrey S. Heier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey S. Heier within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey S. Heier's insider trading performs compared to the benchmark.
Performance of Jeffrey S. Heier
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.1 | | | | | |
| Relative Return to S&P 500(%) | 6 | | | | | |
Jeffrey S. Heier Ownership Network
Ownership Network List of Jeffrey S. Heier
Ownership Network Relation of Jeffrey S. Heier
Jeffrey S. Heier Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Jeffrey S. Heier is the director of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Jeffrey S. Heier made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 31,480 shares made by Antony C. Mattessich , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net purchase of 2,469,312 shares made by Summer Road Llc .
In summary, during the past 3 months, insiders sold 22,712 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 22,712 shares. During the past 18 months, 136,096 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,339,716 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Jeffrey S. Heier Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey S. Heier. You might contact Jeffrey S. Heier via mailing address: C/o Ocular Therapeutix, Inc., 34 Crosby Dr., Suite 105, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
